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Introduction
Postoperative hypoparathyroidism can be one of the complications associated with total thyroid removal due to 
cancer or benign goitre.
Material and methods: We aimed to evaluate the prevalence of hypoparathyroidism in patients operated on due
to thyroid cancer and nodular goitre, including procedures performed between January 2015 and March 2019 at 
the Department of Oncological Surgery of the Medical University of Silesia in Katowice.
The studied group consisted of 595 patients operated on due to cancer and benign nodular goitres. Calcium (Ca) 
and phosphate metabolism was assessed using parathyroid hormone (PTH) and ionised calcium tests four hours 
after the surgery. Ionised calcium was checked 30 days after the procedure. Patients who had borderline or 
below-normal PTH levels in the postoperative period were also subjected to PTH testing after 30 days. In 
patients with low PTH levels, supplementation with calcium and vitamin D3 was introduced after the surgery.
Results: Compared to patients operated on for benign goitres, those diagnosed with cancer were significantly 
more likely to have PTH levels below 15 pg/mL and serum ionised calcium levels below 4 mg/dL 30 days after 
the surgery. The recovery rate was 65.05% vs. 82.6% (p < 0.003) and 64.2% vs. 84.25% (p < 0.001). The results 
were similar among patients who underwent lateral and central lymphadenectomy — 33.3% vs. 67.3% (p < 
0.021) and 25.6% vs. 67.6% (p < 0.018). In patients with mild goitres, no significant differences in the recovery 
rate were observed — 82.6% vs. 92.8% (p < 0.327) and 84.25% vs. 92.3% (p < 0.437). Patients in whom 
parathyroid glands were found in the postoperative material were significantly more likely to have decreased 
PTH and calcium levels 30 days after the procedure. The recovery rate was 64.1% vs. 78.9% (p < 0.027) and 
58.06% vs. 80.8% (p < 0.004).
Conclusions: Hypoparathyroidism is not an uncommon occurrence after thyroidectomy, even in facilities with 
extensive experience in this matter. Compared to total thyroid removal due to benign goitre, surgery for cancer 
with associated central and lateral lymphadenectomy significantly increases the risk of postoperative 
hypoparathyroidism. In surgical practice, it is reasonable to conduct routine Ca and PTH level checks 
immediately after the procedure and 30 days after thyroidectomy.
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Introduction
Complications after thyroidectomy include bleeding, hoarseness of throat, dysphagia, paresis, laryngeal nerve 
palsy and hypoparathyroidism, and less commonly, tracheal instability, lymphorrhoea, and occasionally thyroid 
storm [1, 2]. Postoperative hypoparathyroidism may constitute one of the complications associated with 
thyroidectomy due to cancer and benign goitre. It is usually caused by removal, damage, or ischaemia of the 
parathyroid glands [3, 4].
Material and methods
 A retrospective study on 595 patients with total thyroid removal caused by cancer and benign nodular goitre was
performed between 2015 and March 2019 at the Department of Oncological Surgery of the Medical University 
of Silesia in Katowice. The study was conducted in order to assess the prevalence of hypoparathyroidism, 
defined as serum levels of parathyroid hormone (PTH) < 15 pg/mL (normal 15–60 pg/mL) and ionised calcium 
(Ca) < 4 mg/dL (4–5.2 mg/dL) at four hours and 30 days after surgery, as well as factors that may influence it.
In the case of cancer, the scope of the surgery included total extracapsular removal of the thyroid gland with the 
central lymphatic system and, in some instances, lateral lymphadenectomy. In terms of goitres, the procedure 
involved total extracapsular thyroidectomy. The procedures were performed by four surgeons with years of 
experience.
Parathyroid hormone and Ca levels were not determined before surgery. The check was performed four hours 
after the surgery, and the calcium level was tested the following day. The calcium level was also measured 30 
days after the surgery. In patients with borderline or below normal PTH levels in the postoperative period, the 
PTH was also checked. All patients with low PTH levels received calcium supplementation at 3 g/day and 
alphacalcidol at 2.0 μg/day. In patients with decreased PTH levels as at 30 days after surgery, supplementation 
with calcium and Alfadiol was maintained for another three months. 
The study included an analysis of the prevalence of hypoparathyroidism according to: 
1. The diagnosis: cancer, benign goitres, goitres with inflammation (Hashimoto’s disease).
2. The extent of the surgery: central or lateral lymphadenectomy.
3. The presence of parathyroid glands in postoperative histopathological material (H-P).
The percentage of patients who had normalised levels of PTH and Ca within 30 days of the procedure 
campared to those characterised by abnormal levels immediately after the procedure (recovery rate) was calcu-
lated. The odds ratio is the ratio of the chance of recovery (i.e. normalising PTH or Ca levels if they were below 
normal immediately after the surgery) in the case of a procedure performed in the cancer group compared to that 
of a procedure performed in the group diagnosed with benign goitres.
Statistical analysis
The condition of patients, which is assessed regarding hypoparathyroidism, measured by way of PTH and Ca 
level testing after the surgery and 30 days after the procedure, is summarised in the table below. To determine the
existence of significant differences between the patient groups, the results were compared using the chi-square 
test and Dunn's post-hoc test. The χ2 test was used to examine whether the existing differences in the number of 
healed patients (who had normalised the levels under study) were significant. OR values with 95% confidence 
interval for the compared groups were calculated. 
Results
The study covered 595 patients, including 508 (85.3%) women and 87 (14.6%) men, aged 6 to 86 years, with an 
average of 53 years. 225 cancers, 336 nodular goitres, and 30 nodular goitres with inflammation were diagnosed 
in the H-P. 
Decreased PTH and Ca levels in the group of patients diagnosed with hypoparathyroidism, who did not regain 
normal parathyroid gland function immediately after the surgery and 30 days after the procedure, and the effect 
of the diagnosis, the type of procedure, and the presence of parathyroid glands in H-P on postoperative 
hypoparathyroidism, are presented in Table 1.  
Table 1. Number of patients with parathyroid hormone (PTH) and calcium (Ca) levels below normal in each 
group under study (1 — cancer, 2 — benign goitre), as well as differences in the recovery rate and odds ratio 
values for PTH and Ca as of the day of the surgery and 30 days after the procedure
Paramet
er
Proportion of the healed patients χ2 p OR CI 95% p




















































































5.617 0.018 6.261 1.172 33.449
0.032
OR — odds ratio; CI — confidence interval
The outpatient follow-up check performed six months after the surgery revealed persistent symptoms of 
hypoparathyroidism in seven (1.1%) patients included in the study group with decreased PTH levels after the 
procedure, which required continued calcium and alphacalcidol supplementation.
Discussion
In the study, out of 225 patients operated for cancer, 29 (12.8%) were diagnosed with hypoparathyroidism 30 
days after the surgery; in the group of patients who underwent central lymphadenectomy, it was 23 (10.4%), 
while in those after lateral lymphadenectomy it was 6 (23%). Among 336 persons diagnosed with mild goitres, 
decreased PTH levels were observed in 23 (6.8%), while among those with goitres and associated inflammation 
decreased PTH levels were observed  in 1 (2.9%). The prevalence is comparable to that reported in the literature,
which is between 6.9% and 46% [5, 6].
In the study, parathyroid gland removal was performed on 85 (14.2%) persons, resulting in 
hypoparathyroidism in 13 (2.1%) patients after 30 days, which is lower than the rate reported in the literature on 
the subject, which ranges from 6.4% to 31.1% [7, 8]. However, it still shows that incidental parathyroid gland 
removal is possible and expected. 
The study included a comparison of the prevalence of hypoparathyroidism depending on the diagnosis 
(H-P): cancer, benign goitre, and goitre with inflammation. In terms of the extent of the removal, it includes 
central and lateral lymphadenectomy, as well as the presence of the removed parathyroid gland in H-P. The study
revealed that in significantly more cases, hypoparathyroidism persisting 30 days after the surgery accompanies 
resection of thyroid cancer with central and lateral lymphadenectomy and removal of parathyroid glands 
compared to benign goitre and goitre with associated inflammation. This appears to be consistent with data 
contained in the literature on the subject, where central lymphadenectomy during thyroid removal due to cancer 
is the most common risk factor for hypoparathyroidism [9, 10]. 
The study was limited because not all patients with low PTH levels after 30 days after the surgery 
appeared for a follow-up check in subsequent months. Therefore, the number of patients with decreased PTH 
levels six months after the procedure may be underestimated and amount to more than seven.
Conclusions
Hypoparathyroidism is not an uncommon occurrence after thyroidectomy, even in facilities with 
extensive experience in this matter. Compared to total thyroid removal due to benign goitre, surgery for cancer 
with associated central and lateral lymphadenectomy significantly increases the risk of postoperative 
hypoparathyroidism. In surgical practice, it is reasonable to conduct routine Ca and PTH level checks after the 
procedure and 30 days after thyroidectomy.
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